Login / Signup

Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis.

Susumu YamazakiMasaki ShimizuYuko AkutsuAsami ShimboMasaaki Mori
Published in: Modern rheumatology (2022)
Tacrolimus is an effective and safe therapeutic alternative for approximately 60% of patients with JIA.
Keyphrases
  • juvenile idiopathic arthritis
  • disease activity
  • rheumatoid arthritis
  • systemic lupus erythematosus
  • combination therapy